Mindset Intervention for Cancer
Trial Summary
What is the purpose of this trial?
Primary Objectives: Mindsets have been rigorously studied in the domains of development, education, and more recently, in health and disease. However, there are no large-scale longitudinal studies of the mindsets held by cancer patients and how they may affect treatment outcomes, physical health, and psychological well-being. This randomized, single-blind, treatment-as-usual (TAU) control study aims to assess (1) mindsets at four time points spanning from the point of diagnosis to six weeks post-treatment to patients who are newly diagnosed with cancer and undergoing treatment with curative intent, and (2) the impact of a brief but targeted mindset intervention to help instill more useful mindsets about the nature of cancer and the role of the body on patient reported measures of physical and psychological health. This study aims to add to the existing literature on psychosocial interventions for cancer patients and survivors while addressing the substantial time and cost limitations of traditional interventions. It also contributes to the body of research indicating that mindsets play an important role in both health and wellbeing. Secondary Objectives: This study has two secondary objectives. First, we aim to determine the impact of patient mindsets on measures of treatment (treatment efficacy and treatment related adverse events) and psychosocial health (stress, coping, mood, emotions). Second, we aim to understand the relationship between patient mindsets and biomarkers of immune and inflammatory processes in patients undergoing cancer treatment
Research Team
Alia Crum, PhD
Principal Investigator
Stanford University
Eligibility Criteria
This trial is for English-speaking adults over 18 with a new diagnosis of lung, breast, GI/colorectal cancer or lymphoma and treatment aimed at curing it. They must be able to consent and undergo systemic treatment involving 4-12 infusions. Excluded are those with major health issues reducing life expectancy, active severe mental health diagnoses, pregnant/nursing women, HIV-positive individuals or previous cancer treatments.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a mindset intervention including watching films and reflection activities, or treatment as usual
Follow-up
Participants are monitored for safety and effectiveness after treatment, including assessments of quality of life and biomarkers
Treatment Details
Interventions
- Mindset
- Reflection activities
Find a Clinic Near You
Who Is Running the Clinical Trial?
Stanford University
Lead Sponsor
National Center for Complementary and Integrative Health (NCCIH)
Collaborator